 Deutsche Bank AG trimmed its position in shares of Epizyme Inc NASDAQ:EPZM by 28.2 during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 172,184 shares of the biopharmaceutical companys stock after selling 67,757 shares during the period. Deutsche Bank AG owned about 0.17 of ... 